FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

415544003: Sodium glycerophosphate 4.32g solution for injection 20mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2531464010 Sodium glycerophosphate 4.32g solution for injection 20mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2534993015 Sodium glycerophosphate 4.32g solution for injection 20mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2537702018 Sodium glycerophosphate 4.32g/20mL solution for injection vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2785651000005114 natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml Is a Product containing sodium glycerophosphate (medicinal product) false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sodium glycerophosphate (substance) false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphate false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphate electrolyte false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. elektrolytanionmiddel false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml Has manufactured dose form Solution for injection false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start